Pharmaceutical News

RSS

90.7% of non-cannabis users meet criteria for problematic drug use, shows study

Of emergency patients who reported any drug other than marijuana as their primary drug of use, 90.7 percent met the criteria for problematic drug use.

10 Jul 2014

Can-Fite's CF102 drug gets approval in Israel for patient with hepatocellular carcinoma

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that the Israeli Ministry of Health has approved the use of its drug CF102 for a patient with hepatocellular carcinoma, the most common form of liver cancer, under the country's Compassionate Use Program.

10 Jul 2014

New drug could prove useful in treating small cell lung cancer

Manchester scientists have shown that a new drug could prove useful in treating small cell lung cancer - the most aggressive form of lung cancer.

From The University of Manchester 10 Jul 2014

New class of anti-arthritic drugs reduce arthritic joint inflammation and periodontitis

Inflammatory diseases can occur simultaneously in distinct sites in the same patient, complicating treatment because a medication effective for one disorder may exacerbate the other.

10 Jul 2014

Study reveals effect of 3-n-butylphthalide on chronic ischemic stroke

The pathogenesis of vascular dementia induced by chronic cerebral ischemia is complex, mainly consisting of energy metabolism disorder, oxidative stress injury, neuronal apoptotic cell death and cholinergic nerve dysfunction.

10 Jul 2014

Parkinson's disease drug could also help people with phobias or PTSD

A drug used to treat Parkinson's disease could also help people with phobias or post-traumatic stress disorder (PTSD). Scientists of the Translational Neurosciences Research Center at Johannes Gutenberg University Mainz are currently exploring the effects of psychotherapy to extinguish fears in combination with L-dopa.

10 Jul 2014

Study evaluates investigational drug for moderate to severe endometriosis pain symptoms

Most women know all too well the temporary discomfort associated with menstrual cramps. Women with endometriosis, however, suffer with pain that can be debilitating —not just during their period, but sometimes even during other times of the month.

10 Jul 2014

Letrozole drug results in higher birth rates in women with PCOS

The drug letrozole results in higher birth rates in women with polycystic ovary syndrome (PCOS) than the current preferred infertility treatment drug, according to a nationwide study led by Penn State College of Medicine researchers.

10 Jul 2014

PTC Therapeutics initiates reimbursed expanded access program for Translarna

PTC Therapeutics, Inc. today announced the initiation of a reimbursed expanded access program (EAP). PTC's EAP program is intended to make Translarna (ataluren) available to patients before commercial availability in certain countries.

9 Jul 2014

Astellas seeks isavuconazole approval from FDA for treatment of life-threatening fungal infections

Astellas today announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration seeking approval for isavuconazole for the treatment of invasive aspergillosis and invasive mucormycosis (also known as zygomycosis), life-threatening fungal infections predominantly occurring in immunocompromised patients.

9 Jul 2014

Telemedicine could improve quality of life of patients with chronic liver diseases

Although telemedicine could improve the quality of life of patients with chronic liver diseases, viable home care systems are still lacking. Scientists working on the EU-project "d-LIVER" mean to remedy this situation. Initial results have now been released.

9 Jul 2014

Independent testing organization confirms VSL#3 formulation as probiotic product

Probiotics have gained in popularity in recent years and consumers now have many to choose from. However, only 14 of 19 successfully tested through Consumer Lab's quality certification program probiotics.

9 Jul 2014

FDA approves Protein Sciences' strain change amendment for Flublok influenza vaccine

Protein Sciences Corporation announced today that the FDA has approved the Company's strain change amendment for its seasonal influenza vaccine, Flublok.

9 Jul 2014

Perrigo receives final approval from FDA for congestion relief tablets

Perrigo Company today announced that it was the first to receive final approval from the U.S. Food and Drug Administration for its abbreviated new drug application for ibuprofen and phenylephrine hydrochloride tablets, 200 mg/10 mg (over-the-counter), the store brand equivalent to Advil Congestion Relief Tablets, 200 mg/10 mg.

8 Jul 2014

Use of performance enhancing drugs unmonitored in young elite athletes

The use of performance enhancing drugs is prevalent and unmonitored in junior elite athletes as young as 12, according to research by Griffith University and the University of Canberra that will be presented tomorrow.

8 Jul 2014

KoACT supplement optimal for bone strength, flexibility in post-menopausal women

Data presented at April's Experimental Biology 2014 Annual Scientific Meeting shows that KoACT, a dietary supplement that combines a proprietary formulation of calcium and collagen is optimal for bone strength and flexibility in post-menopausal women.

8 Jul 2014

Reaction Biology awarded Phase I SBIR grant to create epigenetic database

Reaction Biology Corporation announced today that it has been awarded a Phase I SBIR grant from the National Center for Advancing Translational Sciences to create a database of epigenetic drug interactions.

8 Jul 2014

Survey shows biggest barrier to receiving Human Papillomavirus vaccine

A survey of first-year Grand Valley State University students showed the biggest barrier to receiving a Human Papillomavirus (HPV) vaccine was moral or religious beliefs, or a perceived promotion of sexual behavior, according to graduate physician assistant researchers.

8 Jul 2014

CASI's ENMD-2076 gets FDA Orphan Drug designation for HCC treatment

CASI Pharmaceuticals, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and other diseases, announced today that its orally-active, Aurora A/angiogenic kinase inhibitor, ENMD-2076, has received Orphan Drug designation from the U.S. Food and Drug Administration for the treatment of hepatocellular carcinoma (HCC).

7 Jul 2014

$FDA grants Breakthrough Therapy status to Novartis' CTL019 for treatment of relapsed/refractory ALL$

FDA grants Breakthrough Therapy status to Novartis' CTL019 for treatment of relapsed/refractory ALL

Novartis announced today that the United States Food and Drug Administration has granted Breakthrough Therapy status to CTL019, an investigational chimeric antigen receptor (CAR) therapy for the treatment of pediatric and adult patients with relapsed/refractory acute lymphoblastic leukemia (r/r ALL).

7 Jul 2014

Pharmaceutical News

90.7% of non-cannabis users meet criteria for problematic drug use, shows study

Can-Fite's CF102 drug gets approval in Israel for patient with hepatocellular carcinoma

New drug could prove useful in treating small cell lung cancer

New class of anti-arthritic drugs reduce arthritic joint inflammation and periodontitis

Study reveals effect of 3-n-butylphthalide on chronic ischemic stroke

Parkinson's disease drug could also help people with phobias or PTSD

Study evaluates investigational drug for moderate to severe endometriosis pain symptoms

Letrozole drug results in higher birth rates in women with PCOS

PTC Therapeutics initiates reimbursed expanded access program for Translarna

Astellas seeks isavuconazole approval from FDA for treatment of life-threatening fungal infections

Telemedicine could improve quality of life of patients with chronic liver diseases

Independent testing organization confirms VSL#3 formulation as probiotic product

FDA approves Protein Sciences' strain change amendment for Flublok influenza vaccine

Perrigo receives final approval from FDA for congestion relief tablets

Use of performance enhancing drugs unmonitored in young elite athletes

KoACT supplement optimal for bone strength, flexibility in post-menopausal women

Reaction Biology awarded Phase I SBIR grant to create epigenetic database

Survey shows biggest barrier to receiving Human Papillomavirus vaccine

CASI's ENMD-2076 gets FDA Orphan Drug designation for HCC treatment

FDA grants Breakthrough Therapy status to Novartis' CTL019 for treatment of relapsed/refractory ALL

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News